Source: Annual Congress 2010 - COPD exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Skoczynski, K. Mizia-Stec, A. Semik-Orzech, E. Sozanska, Z. Gasior, W. Pierzchala (Katowice, Poland). Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation. Eur Respir J 2010; 36: Suppl. 54, 545

Member's Comments

No comment yet.

Related content which might interest you: Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Source: Eur Respir J 2004; 23: 832-840 Year: 2004 Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006 Lung hyperinflation in COPD: the impact of pharmacotherapy Source: Eur Respir Rev 2006; 15: 85-89 Year: 2006 Heliox, dyspnoea and exercise in COPD Source: Eur Respir Rev 2009; 19: 30-38 Year: 2010 Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD Source: Eur Respir J 2004; 24: 385-390 Year: 2004 Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 86-94 Year: 2004 Physiology and consequences of lung hyperinflation in COPD Source: Eur Respir Rev 2006; 15: 61-67 Year: 2006 Dyspnoea Source: Respipedia Article Year: 2016 Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III Source: Eur Respir J 2006; 28: 939-944 Year: 2006 Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance Source: Eur Respir Rev 2006; 15: 37-41 Year: 2006 The relationship between the lung function and dyspnea, cough, and exercise capacity in the not-treated COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Mechanisms limiting exercise in COPD: new insights Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease Year: 2005 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Evaluation of bronchodilator responses in patients with "irreversible" emphysema Source: Eur Respir J 2001; 18: 914-920 Year: 2001 Mechanisms of dyspnoea and its language in patients with asthma Source: Eur Respir J 2006; 27: 742-747 Year: 2006 New strategies to improve exercise capacity in COPD Source: Annual Congress 2006 - MP1 – New strategies to improve exercise capacity in COPD Year: 2006 Is exercise tolerance different in COPD and bronchiectasis patients who are severely obstructed? Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD Source: Eur Respir J 2009; 34: 866-874 Year: 2009